Widgets for Webmasters
TREDAPTIVE(TM) (Nicotinic Acid /Laropiprant) Approved in the European Union: New Lipid-Modifying...
redorbit.com Jul 11, 2008 8 relatedMerck Sharp & Dohme (MSD) announced today that TREDAPTIVE(TM) (nicotinic acid/laropiprant, MSD) 1 g/20 mg modified-release tablets, a new lipid-modifying therapy for patients with dyslipidemia and primary hypercholesterolemia,...

